Simulating a bacterial infection characteristic for cholesteatoma, we observed a highly significant increase in expression of TNF-α in ME-CSCs in response to treatment with the TLR4-ligand LPS in comparison to ACSCs and untreated ME-CSCs (Fig. 5B). The gene discussed is TLR4; the disease is cholesteatoma.